Literature DB >> 8419458

Bone sialoprotein (BSP) secretion and osteoblast differentiation: relationship to bromodeoxyuridine incorporation, alkaline phosphatase, and matrix deposition.

P Bianco1, M Riminucci, E Bonucci, J D Termine, P G Robey.   

Abstract

We defined two distinct maturational compartments (proliferative and secretory) of osteogenic cells in vivo on the basis of ALP activity, BrdU incorporation, cell shape, and BSP production. BSP immunoreactivity was found to mark cells in the secretory but not in the proliferative compartment. We established the phenotypic similarity of primitive marrow stromal cells with proliferating perichondral cells (fibroblast-like, ALP+, BrdU+, BSP-). This suggests the potential functional equivalence of the two cell types as committed non-secretory osteogenic cells and points to the duality of osteogenic cell compartments as a generalized feature of bone formation. We further showed that although BSP secretion is a hallmark of the onset of osteogenesis, BSP antigenicity is lost both in osteoid and in a large proportion of mature osteoblasts during subsequent phases of bone deposition. This suggests that bone formation may not be a uniform event, as bone cells actually deposit antigenically, and likely biochemically, distinct matrices at specific times.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419458     DOI: 10.1177/41.2.8419458

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  16 in total

1.  Ablation of systemic phosphate-regulating gene fibroblast growth factor 23 (Fgf23) compromises the dentoalveolar complex.

Authors:  E Y Chu; H Fong; F A Blethen; K A Tompkins; B L Foster; K D Yeh; K J Nagatomo; D Matsa-Dunn; D Sitara; B Lanske; R B Rutherford; M J Somerman
Journal:  Anat Rec (Hoboken)       Date:  2010-07       Impact factor: 2.064

2.  Lack of in vitro evidence for storage of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and 1,25(OH)2D3 binding protein in skeletal matrix.

Authors:  S Boonen; J Aerssens; I Jans; E Van Herck; I Vandewal; J Peeters; R Van den Eynde; J Dequeker; R Bouillon
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

3.  The anatomy of bone sialoprotein immunoreactive sites in bone as revealed by combined ultrastructural histochemistry and immunohistochemistry.

Authors:  M Riminucci; G Silvestrini; E Bonucci; L W Fisher; P Gehron Robey; P Bianco
Journal:  Calcif Tissue Int       Date:  1995-10       Impact factor: 4.333

Review 4.  Control of stem cell fate by engineering their micro and nanoenvironment.

Authors:  Michelle F Griffin; Peter E Butler; Alexander M Seifalian; Deepak M Kalaskar
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

5.  Human mesenchymal stem cell position within scaffolds influences cell fate during dynamic culture.

Authors:  Andrew B Yeatts; Elyse M Geibel; Fayola F Fears; John P Fisher
Journal:  Biotechnol Bioeng       Date:  2012-04-08       Impact factor: 4.530

6.  Ability of bone graft substitutes to support the osteoprogenitor cells: An in-vitro study.

Authors:  Ziad Dahabreh; Michalis Panteli; Ippokratis Pountos; Mark Howard; Peter Campbell; Peter V Giannoudis
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

7.  Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition.

Authors:  Michaël Chaplet; Cédric Detry; Christophe Deroanne; Larry W Fisher; Vincent Castronovo; Akeila Bellahcéne
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

Review 8.  Skeletal stem cells.

Authors:  Paolo Bianco; Pamela G Robey
Journal:  Development       Date:  2015-03-15       Impact factor: 6.868

9.  Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation.

Authors:  M Riminucci; L W Fisher; A Shenker; A M Spiegel; P Bianco; P Gehron Robey
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

10.  Enhanced in vivo osteogenesis by nanocarrier-fused bone morphogenetic protein-4.

Authors:  Yasuyuki Shiozaki; Takashi Kitajima; Tetsuro Mazaki; Aki Yoshida; Masato Tanaka; Akihiro Umezawa; Mariko Nakamura; Yasuhiro Yoshida; Yoshihiro Ito; Toshifumi Ozaki; Akihiro Matsukawa
Journal:  Int J Nanomedicine       Date:  2013-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.